BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12213220)

  • 1. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor.
    Yoshimoto Y; Imoto M
    Exp Cell Res; 2002 Sep; 279(1):118-27. PubMed ID: 12213220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vacuolar-type H(+)-ATPase inhibitory activity of synthetic analogues of the concanamycins: is the hydrogen bond network involving the lactone carbonyl, the hemiacetal hydroxy group, and the C-19 hydroxy group essential for the biological activity of the concanamycins?
    Yoshimoto Y; Jyojima T; Arita T; Ueda M; Imoto M; Matsumura S; Toshima K
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3525-8. PubMed ID: 12443768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
    Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T
    Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases.
    Bowman EJ; Gustafson KR; Bowman BJ; Boyd MR
    J Biol Chem; 2003 Nov; 278(45):44147-52. PubMed ID: 12944415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of efrapeptin and destruxin, metabolites of entomogenous fungi, on the hydrolytic activity of a vacuolar type ATPase identified on the brush border membrane vesicles of Galleria mellonella midgut and on plant membrane bound hydrolytic enzymes.
    Bandani AR; Amiri B; Butt TM; Gordon-Weeks R
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):367-77. PubMed ID: 11342173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity.
    Togashi K; Kataoka T; Nagai K
    Immunol Lett; 1997 Mar; 55(3):139-44. PubMed ID: 9161879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
    Muroi M; Shiragami N; Takatsuki A
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1358-65. PubMed ID: 7802670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
    Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
    Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1.
    Skarpen E; Johannessen LE; Bjerk K; Fasteng H; Guren TK; Lindeman B; Thoresen GH; Christoffersen T; Stang E; Huitfeldt HS; Madshus IH
    Exp Cell Res; 1998 Aug; 243(1):161-72. PubMed ID: 9716460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway.
    Sasazawa Y; Futamura Y; Tashiro E; Imoto M
    Cancer Sci; 2009 Aug; 100(8):1460-7. PubMed ID: 19459857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.
    Horova V; Hradilova N; Jelinkova I; Koc M; Svadlenka J; Brazina J; Klima M; Slavik J; Hyrslova Vaculova A; Andera L
    FEBS J; 2013 Jul; 280(14):3436-50. PubMed ID: 23678861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells.
    Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2007 Feb; 30(2):254-60. PubMed ID: 17268061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
    Kim K; Wu HG; Jeon SR
    Anticancer Res; 2015 Jan; 35(1):245-53. PubMed ID: 25550557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
    Lichtner RB; Menrad A; Sommer A; Klar U; Schneider MR
    Cancer Res; 2001 Aug; 61(15):5790-5. PubMed ID: 11479217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and assignment of the absolute configuration of indenotryptoline bisindole alkaloid BE-54017.
    Kimura T; Kanagaki S; Matsui Y; Imoto M; Watanabe T; Shibasaki M
    Org Lett; 2012 Sep; 14(17):4418-21. PubMed ID: 22917065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
    Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
    Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.
    Micheau O; Solary E; Hammann A; Martin F; Dimanche-Boitrel MT
    J Natl Cancer Inst; 1997 Jun; 89(11):783-9. PubMed ID: 9182976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
    Shinohara H; Yagita H; Ikawa Y; Oyaizu N
    Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.